Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Classifica tra le azioni
#4334
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Prezzo delle azioni
$3.87
Capitalizzazione di mercato
$3.57B
Variazione (1 giorno)
-1.64%
Variazione (1 anno)
9.08%
Paese
CN
Scambia Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Categoria
Healthcare
Margine operativo per Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Margine operativo al October 2026 TTM: 34.04%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Hubei Jumpcan Pharmaceutical Co., Ltd., il margine operativo attuale (TTM) è 34.04%. Alla fine del 2024, il margine operativo era 35.71%.
Storico del margine operativo per Hubei Jumpcan Pharmaceutical Co., Ltd. da 2001 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 34.04% | -1.90% |
| 2025 | 34.70% | -2.83% |
| 2024 | 35.71% | 5.81% |
| 2023 | 33.75% | 25.28% |
| 2022 | 26.94% | 6.36% |
| 2021 | 25.33% | 6.29% |
| 2020 | 23.83% | -10.98% |
| 2019 | 26.77% | 1.48% |
| 2018 | 26.38% | 8.74% |
| 2017 | 24.26% | 7.35% |
| 2016 | 22.60% | 12.72% |
| 2015 | 20.05% | 6.08% |
| 2014 | 18.90% | 11.57% |
| 2013 | 16.94% | 28.72% |
| 2012 | 13.16% | 561.31% |
| 2011 | 1.99% | -36.01% |
| 2010 | 3.11% | -60.98% |
| 2009 | 7.97% | -15.57% |
| 2008 | 9.44% | 97.08% |
| 2007 | 4.79% | -30.17% |
| 2006 | 6.86% | -38.42% |
| 2005 | 11.14% | 0.72% |
| 2004 | 11.06% | 18.80% |
| 2003 | 9.31% | -47.73% |
| 2002 | 17.81% | -2.78% |
| 2001 | 18.32% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 10.52% | -99.69% |
JP
|
|
| 17.08% | -99.50% |
CH
|
|
| 22.93% | -99.33% |
IN
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.